Related references
Note: Only part of the references are listed.In Vitro and In Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis
Jian Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?
Isobella Honeyborne et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Modular epistasis and the compensatory evolution of gene deletion mutants
Jose I. Rojas Echenique et al.
PLOS GENETICS (2019)
Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps
Hasan Ghajavand et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay
Carolina de Miranda Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates
Jalil Kardan-Yamchi et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
Geoff Melly et al.
MICROORGANISMS (2019)
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
Anastasia Koch et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
Navisha Dookie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates
Nontuthuko E. Maningi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study
Gabriella Ferlazzo et al.
LANCET INFECTIOUS DISEASES (2018)
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
H. M. Adnan Hameed et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Mechanisms of Bacterial Tolerance and Persistence in the Gastrointestinal and Respiratory Environments
R. Trastoy et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance
Sakshi Luthra et al.
FRONTIERS IN MICROBIOLOGY (2018)
Tuberculosis elimination where are we now?
Alberto Matteelli et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Tuberculosis and lung damage: from epidemiology to pathophysiology
Shruthi Ravimohan et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
Rajendra Prasad et al.
LUNG INDIA (2018)
New drugs and perspectives for new anti-tuberculosis regimens
S. Tiberi et al.
PULMONOLOGY (2018)
Emerging drugs and drug targets against tuberculosis
Nzungize Lambert et al.
JOURNAL OF DRUG TARGETING (2017)
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations
C. C. Heuvelings et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Novel approaches to tuberculosis vaccine development
Stefan H. E. Kaufmann et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar Ud Din et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers
Chih-Hung Lin et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2017)
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria
Mohammad J. Nasiri et al.
FRONTIERS IN MICROBIOLOGY (2017)
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
Mashael Al-Saeedi et al.
INFECTION AND DRUG RESISTANCE (2017)
Contribution of Putative Efflux Pump Genes to Isoniazid Resistance in Clinical Isolates of Mycobacterium tuberculosis
Anshika Narang et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2017)
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Sebastian M. Gygli et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Ben Gold et al.
MICROBIOLOGY SPECTRUM (2017)
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Daniel T. Hoagland et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Antibiotic resistance mechanisms in M-tuberculosis: an update
Liem Nguyen
ARCHIVES OF TOXICOLOGY (2016)
Drug-Resistant Tuberculosis Challenges and Progress
Sebastian G. Kurz et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis
Maha R. Farhat et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings
Derek J. Sloan et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2016)
Tuberculosis
Madhukar Pai et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Tuberculosis 2015: burden, challenges and strategy for control and elimination
Mario Raviglione et al.
INFECTIOUS DISEASE REPORTS (2016)
New antituberculosis drugs: from clinical trial to programmatic use
Gina Gualano et al.
INFECTIOUS DISEASE REPORTS (2016)
Mechanisms of Antibiotic Resistance
Jose M. Munita et al.
MICROBIOLOGY SPECTRUM (2016)
Tuberculosis Infection and Latent Tuberculosis
Seung Heon Lee
TUBERCULOSIS AND RESPIRATORY DISEASES (2016)
Targets for Combating the Evolution of Acquired Antibiotic Resistance
Matthew J. Culyba et al.
BIOCHEMISTRY (2015)
Controlled drug release from pharmaceutical nanocarriers
Jinhyun Hannah Lee et al.
CHEMICAL ENGINEERING SCIENCE (2015)
The End TB Strategy: India can blaze the trail
Madhukar Pai
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
Tuberculosis and chronic respiratory disease: a systematic review
Anthony L. Byrne et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Kwonjune J. Seung et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Molecular mechanisms of antibiotic resistance
Jessica M. A. Blair et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates
Guilian Li et al.
PLOS ONE (2015)
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
Marva Seifert et al.
PLOS ONE (2015)
Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan
Jann-Yuan Wang et al.
PLOS ONE (2015)
Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression
Hyejin Kim et al.
SCIENTIFIC REPORTS (2015)
Molecular Mechanisms Underlying Bacterial Persisters
Etienne Maisonneuve et al.
CELL (2014)
Carrier-Based Drug Delivery System for Treatment of Acne
Amber Vyas et al.
SCIENTIFIC WORLD JOURNAL (2014)
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
Anastasia Koch et al.
EMERGING MICROBES & INFECTIONS (2014)
Tuberculosis in Tropical Areas and Immigrants
Lorenzo Zammarchi et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2014)
Drug Resistance Mechanisms in Mycobacterium tuberculosis
Juan Carlos Palomino et al.
ANTIBIOTICS-BASEL (2014)
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
Vegard Eldholm et al.
GENOME BIOLOGY (2014)
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
Stellah G. Mpagama et al.
BMC INFECTIOUS DISEASES (2013)
Chemical and Structural Insights into the Regioversatility of the Aminoglycoside Acetyltransferase Eis
Jacob L. Houghton et al.
CHEMBIOCHEM (2013)
The Expression of ABC Efflux Pump, Rv1217c-Rv1218c, and Its Association with Multidrug Resistance of Mycobacterium tuberculosis in China
Ke Wang et al.
CURRENT MICROBIOLOGY (2013)
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections
Kristin J. Labby et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Ben J. Marais et al.
LANCET INFECTIOUS DISEASES (2013)
Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance
Jun Tao et al.
NUCLEIC ACIDS RESEARCH (2013)
The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis
Borna Mueller et al.
TRENDS IN GENETICS (2013)
Vaccine delivery using nanoparticles
Anthony E. Gregory et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
Tae Sun Shim et al.
INFECTION AND CHEMOTHERAPY (2013)
Targeting Persisters for Tuberculosis Control
Ying Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Aminoglycoside Multiacetylating Activity of the Enhanced Intracellular Survival Protein from Mycobacterium smegmatis and Its Inhibition
Wenjing Chen et al.
BIOCHEMISTRY (2012)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
Dynamic Population Changes in Mycobacterium tuberculosis During Acquisition and Fixation of Drug Resistance in Patients
Gang Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Extensively Drug-Resistant Tuberculosis: A Review Article
Payam Tabarsi et al.
ARCHIVES OF CLINICAL INFECTIOUS DISEASES (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
New Regimens for Reducing the Duration of Treatment of Drug-Susceptible Pulmonary Tuberculosis
Marcus B. Conde et al.
DRUG DEVELOPMENT RESEARCH (2011)
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Pedro Eduardo Almeida Da Silva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Aminoglycoside modifying enzymes
Maria S. Ramirez et al.
DRUG RESISTANCE UPDATES (2010)
New drugs and regimens for treatment of TB
Eric Leibert et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Novel technologies: A weapon against tuberculosis
B. N. Vedha Hari et al.
INDIAN JOURNAL OF PHARMACOLOGY (2010)
Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli Super Extensively Drug-Resistant Tuberculosis or Totally Drug-Resistant Strains in Iran
Ali Akbar Velayati et al.
CHEST (2009)
Quinolones: Action and Resistance Updated
Karl Drlica et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Clinical and operational value of the extensively drug-resistant tuberculosis definition
G. B. Migliori et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Extensively drug-resistant tuberculosis, Italy and Germany
Giovanni Battista Migliori et al.
EMERGING INFECTIOUS DISEASES (2007)
Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam
M. Caws et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
LJV Piddock
CLINICAL MICROBIOLOGY REVIEWS (2006)
M-tuberculosis persistence, latency, and drug tolerance
JE Gomez et al.
TUBERCULOSIS (2004)
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
A Somoskovi et al.
RESPIRATORY RESEARCH (2001)
Share Paper
